Insurance barriers and inequalities in health care access: evidence from dual practice.

ABSTRACT:

Background

We investigate access disparities in pharmaceutical care among German patients with type 2 diabetes, focusing on differences between public and private health insurance schemes. The primary objectives include investigating whether patients with private health insurance experience enhanced access to antidiabetic care and analyzing whether the treatment received by public and private patients is influenced by the practice composition, particularly the proportion of private patients.

Methods

We estimate fixed effect regression models, to isolate the effect of insurance schemes on treatment choices. We utilize data from a prescriber panel comprising 681 physicians collectively serving 68,362 patients undergoing antidiabetic treatments.

Results

The analysis reve

SUBMITTER: Goetjes E 

PROVIDER: S-EPMC10956272 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature